NDATOPICALGEL
Approved
Mar 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
TOPICORT (desoximetasone) by Design Pharmaceuticals is corticosteroid hormone receptor agonists [moa]. Approved for plaque psoriasis in patients 18 years of age, older (), older and 1 more indications. First approved in 1982.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TOPICORT (desoximetasone) is a topical corticosteroid gel approved in 1982 for plaque psoriasis in adults 18 years and older. It works by acting as a corticosteroid hormone receptor agonist to reduce inflammation and immune response in affected skin. The drug is administered topically as a gel formulation.
LOE Approaching
As LOE approaches, the commercial team is likely in optimization and retention mode with smaller team footprint than growth-stage products.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Indications (4)
Worked on TOPICORT at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.